Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01VJN
|
|||
| Former ID |
DIB001235
|
|||
| Drug Name |
Olanzapine/fluoxetine combination
|
|||
| Synonyms |
Symbyax (Zyprexa/Prozac)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Depression [ICD-11: 6A70-6A7Z; ICD-9: 311] | Approved | [1] | |
| Company |
Eli Lilly; Eli Lilly & Co
|
|||
| Structure |
 |
Download2D MOL |
||
| Canonical SMILES |
CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C.CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Serotoninnorepinephrinedopamine reuptake (SNDR) | Target Info | Antagonist | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.